These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5373168)

  • 1. Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. V. Stimulatory effect of diphenylhydantoin and phenobarbital on the D-glucaric acid synthesis in man.
    Okada M; Matsui M; Kaizu T; Abe F
    Chem Pharm Bull (Tokyo); 1969 Dec; 17(12):2625-8. PubMed ID: 5373168
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. 3. Determination of D-glucaric acid in serum, with special reference to its level after administration of d-glucuronolactone and D-glucarolactones to man.
    Matsui M; Kaizu T; Okada M; Ishidate M
    Chem Pharm Bull (Tokyo); 1969 Sep; 17(9):1871-7. PubMed ID: 5347593
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
    Szeberenyi S; Tacconi MT; Garattini S
    Endocrinology; 1969 Sep; 85(3):575-6. PubMed ID: 5793035
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. II. Excretion of D-glucaric acid in urine after administration of several monosaccharides and their derivatives to mammals.
    Matsui M; Okada M; Ishidate M
    Chem Pharm Bull (Tokyo); 1969 May; 17(5):1064-71. PubMed ID: 5821771
    [No Abstract]   [Full Text] [Related]  

  • 5. Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone?
    Latham AN; Richens A
    Br J Pharmacol; 1973 Mar; 47(3):615P. PubMed ID: 4730837
    [No Abstract]   [Full Text] [Related]  

  • 6. The excretion of metabolites of the D-glucuronic acid pathway in human urine. Effect of phenobarbitone administration.
    Lake BG; Longland RC; Harris RA; Gangolli SD; Rundle A
    Xenobiotica; 1982 Apr; 12(4):241-7. PubMed ID: 7113260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucaric acid excretion as index of hepatic glucuronidation in neonates after phenobarbital treatment.
    Talafant E; Hosková A; Pojerová A
    Pediatr Res; 1975 May; 9(5):480-3. PubMed ID: 1134846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.
    Cunningham JL; Evans DA
    Eur J Clin Pharmacol; 1974 Aug; 7(5):387-91. PubMed ID: 4417891
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement by phenobarbital and diphenylhydantoin of carbon monoxide production in normal man.
    Coburn RF
    N Engl J Med; 1970 Sep; 283(10):512-5. PubMed ID: 5434134
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].
    Tutor JC; Fernández MP; Paz JM
    Arch Farmacol Toxicol; 1982 Apr; 8(1):37-44. PubMed ID: 7138085
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
    Hermida J; Fernández MP; Tutor JC
    Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro.
    Hahn TJ; Scharp CR; Richardson CA; Halstead LR; Kahn AJ; Teitelbaum SL
    J Clin Invest; 1978 Aug; 62(2):406-14. PubMed ID: 209062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of diphenylhydantoin and phenobarbital on the liver of the pig.
    Dam M; Moller JE; Petersen P
    Epilepsia; 1969 Dec; 10(4):507-19. PubMed ID: 5264689
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary D-glucaric acid. An index of heparin microsomal enzyme activity in human females.
    Fahim MS; Hall DG; Fahim Z
    Am J Obstet Gynecol; 1969 Sep; 105(1):124-6. PubMed ID: 5805242
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of folic acid on the anticonvulsive action of phenobarbital and diphenylhydantoin.
    Czarnecka E; Zajac A; Malafiej E; Dramiński M
    Acta Physiol Pol; 1975; 26(2):183-8. PubMed ID: 1146565
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of diphenylhydantoin and phenobarbital on protein metabolism in the rat cerebral cortex.
    Jones GL; Woodbury DM
    Biochem Pharmacol; 1976 Jan; 25(1):53-61. PubMed ID: 1252257
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic drug metabolism after phenobarbital and diphenylhydantoin administration in the rat--influence of vitamin D3 status.
    Gascon-Barré M; Côte MG; Brodeur J
    Biochem Pharmacol; 1979; 28(2):313-9. PubMed ID: 218591
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary d-glucaric acid excretion as a measure of hepatic enzyme induction in man.
    Hunter J; Maxwell JD; Carrella M; Stewart DA; Williams R
    Clin Sci; 1971 Mar; 40(3):10P. PubMed ID: 5550888
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of the anticonvulsants phenobarbital and diphenylhydantoin on intestinal absorption of calcium.
    Foss MC; Meneghelli UG; Tabosa Veríssimo JM
    Acta Physiol Lat Am; 1979; 29(4-5):223-8. PubMed ID: 263172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice.
    Melamed E; Martinovits G; Pikarsky E; Rosenthal J; Uzzan A
    Eur J Pharmacol; 1986 Sep; 128(3):255-7. PubMed ID: 3491762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.